Use of lactobacillus for reduction of the fibrinogen level in blood
US6214336A · kind A · utility
18Cited by
2References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 7, 2000 |
| Grant date | Apr 10, 2001 |
| Priority date | — |
| Expiry date | Feb 7, 2020 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S435/857
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention refers to the use of a strain of Lactobacillus for the manufacture of a medicament for reduction of the fibrinogen level, and optionally cholesterol level, in blood. Said medicament can be utilized for the prophylaxis and/or treatment of circulatory diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.